Pindolol
- Product NDC
- 10135-743
- 11-digit product format
- 101350743
- Labeler code
- 10135
- Product ID
- 10135-743_4a2bd5cb-bdc6-a71d-e063-6394a90a9a53
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pindolol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Marlex Pharmaceuticals, Inc.
- Application
- ANDA073609
- Marketing category
- ANDA
- Marketing start
- 2022-06-01
- Substance
- PINDOLOL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Pindolol
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PINDOLOL | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | BJ4HF6IU1D |
| Rxcui | 198104, 198105 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 10135-743-01 | Pindolol | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 10135-743 | PINDOLOL TABLET [MARLEX PHARMACEUTICALS, INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20241016_e1049edf-376e-317b-e053-2995a90a2aac.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10135-743-01 | 10135074301 | 100 TABLET in 1 BOTTLE (10135-743-01) | 100 tablet | 2022-06-01 | 0000-00-00 | No | No | Current |